Dr. Jun Zhang’s project “ALCAT1 as a Novel Target for the Treatment of Cardiomyopathy in Barth Syndrome” has been accepted and fully funded for a two-year period by the Barth Syndrome Foundation. Dr. Zhang is an Instructor/Research in the lab of Dr. Yuguang Shi with the Sam and Ann Barshop Institute for Longevity and Aging Studies and the Department of Pharmacology.